Achievement‎ > ‎

Achievement


Book Chapters (selected)

[1] Barfoot, J., Kemp E., Doherty, K., Blackburn, C., Sengoku, S., van Servellen, A., Garavi, A., Karlsson, A., Stem Cell Research: Trends and Perspectives on the Evolving International Landscape, Elsevier B. V., Amsterdam (2013)

[2] Sengoku, S., Innovation and Commercialization of Induced Pluripotent Stem Cells, in Vertès, A. A., Qureshi, N., Caplan, A. I., Babssis, L. (eds) Stem Cell in Regenerative Medicine: Science, Regulation and Business Strategies, Wiley, Chichester, 2015. ISBN: 978-1-119-97139-9


Peer-Reviewed Articles

[1] Touhara, K., Sengoku, S., Inaki, K., Tsuboi, A., Hirono, J., Sato, T., Sakano, H., Haga, T., Functional identification and reconstitution of an odorant receptor in single olfactory neurons. Proc Natl Acad Sci U S A 96(7):4040-5 (1999), Erratum in: Proc Natl Acad Sci U S A 97(7):3782 (2000)

[2] Sengoku, S., Ishii, T., Serizawa, S., Nakatani, H., Nagawa, F., Tsuboi, A., Sakano, H., Axonal projection of olfactory sensory neurons during the developmental and regeneration processes, NeuroReport 12(5):1061-6 (2001)

[3] Shibayama, S., Tanikawa, K., Kono, J., Tanaka, N., Ebata, T., Sengoku, S., Kimura, H., Analysis of Pre-M&A Process of Japanese Pharmaceutical Company : A Case Study of Astellas Pharma Merger [in Japanese], Journal of health care and society 16(3):249-273 (2007)

[4] Takahashi, K., Sengoku, S., Kimura, H., Analysis on Productivity of a Clinical Study across Asian Countries ? a Case Comparison. Drug Discovery and Therapeutics 1(1):4-8 (2007)

[5] Sengoku, S., Murasawa, Y., Kimura, H., Expression of post-merger effect in R&D function of Japanese pharmaceutical companies: a case of Astellas Pharma, Journal of health care and society 18(2):273-289 (2008) [in Japanese]

[6] Sengoku, S., Takahashi, K., Kimura, H., Transaction process redesign in the pharmaceutical industry: an institutional approach to realize open innovation, Journal of Intellectual Property Association of Japan 5(3):48-64 (2009)  [in Japanese]

[7] Hayashi, M., Sengoku, S., Hoshi, S., Kimura, H., Gaps in the information sharing on consumer healthcare products. Drug Discovery and Therapeutics 3(2):37-40 (2009)

[8] Takahashi, K., Sengoku, S., Kimura, H., Driving clinical study efficiencies by using a productivity breakdown model: Comparative evaluation of a global clinical study and a similar Japanese study, Journal of Clinical Pharmacy and Therapeutics 36:87-98 (2011)

[9] Sengoku, S., Yoda, T., Seki, A., Assessment of Pharmaceutical Research & Development Productivity with a Novel Net Present Value-Based Project Database, Drug Information Journal 45(2):175-185 (2011)

[10] Sengoku, S., Sumikura, K., Oki, T., Nakatsuji, N., Redefining the Concept of Standardization for Pluripotent Stem Cells, Stem Cell Reviews and Reports 7(2):221-226 (2011)

[11] Anzai, T., Kusama, R., Kodama, H., Sengoku, S., Holistic observation and monitoring of the impact of interdisciplinary academic research projects: An empirical assessment in Japan, Technovation 32(6):345-57 (2012)

[12] Kodama, H., Watatani, K., Sengoku, S. Competency-based Assessment of Academic Interdisciplinary Research and Implication to University Management, Research Evaluation 22, 93-104 (2013)

[13Watatani, K., Xie, Z., Nakatsuji, N., Sengoku, S. Global Competencies from Regional Stem Cell Research: Bibliometrics for Investigating and Forecasting Research TrendsRegenerative Medicine 8(5):659-668 (2013)

[14] HHamada, S., Shibata, A., Urushihara, H., Sengoku, S., Suematsu, C., Kawakami, K., Transaction Cost Analysis of the New Drug Application Process: A Case Study of a Multinational Pharmaceutical Company in Japan, Therapeutic Innovation & Regulatory Science 48(3):371-377, 2014.

[15Munisi H.I., Xie, Z, Sengoku, S, Exploring the Innovation of Stem Cells and Regenerative Medicine in Japan: The Power of Consortium-Based Approach, Regenerative Medicine, 9(4):467-477 (2014)

[16] Anzai, T., Kimura, H., Sengoku, S., The Management of Academic Interdisciplinary and Fusion R&D Projects based on Activity Indicators: A Case Study of Advanced Medical-Engineering Collaborative Institute. The Journal of the Japanese Society for Science Policy and Research Management, 29(2/3):106-117 (2014) [in Japanese]

[17Lauto, G., Sengoku, S., Perceived incentives to transdisciplinarity in a Japanese university research center, Futures, 65:136-149 (2015)

[18] Sengoku, S., Yashiro, Y., Sakurai, M., Japan’s regulatory framework: seeking to provide impetus to the commercialization of regenerative medicine products, Cell & Gene Therapy Insights, doi: 10.18609.cgti.2015.008 (2015)

[19] Anzai, T., Sengoku, S., Managing Academic Interdisciplinary Research towards Innovation: A Resource and Communication-Based Approach, Technology Transfer and Entrepreneurship, 3(2), 70-81 (2016)

[20] Hanaki, N., Sengoku, S., Imanaka, Y., Kawakami, K. The Clinical Application of Medical Science Research: Investment and Duration, Journal of Translational Science, 2(5),  272-276 (2016)

[21] Avila-Robinson, A., Sengoku, S., Multilevel exploration of the realities of interdisciplinary research centers for the management of knowledge integration, Technovation, doi: 10.1016.j.technovation.2017.01.003 (2017)

[22] Avila-Robinson, A., Sengoku, S., Tracing the knowledge-building dynamics in new stem cell technologies through techno-scientific networks, Scientometrics, Accepted.

Other articles (selected)

[1] Anzai, T., Sengoku, S., Collaboration of Policy Science with Research & Development Practices, the Journal of Science Policy and Research Management 27(3/4):210-225 (2012) [in Japanese]

[2] Munisi, H. I., Yen L., Jolivet, E., Sengoku, S., International Dynamics of Biotech Industrial Clusters: Reviewing the Medicon Valley and Lyon in order to Draw Lessons for the Kansai Bio-Cluster [in Japanese], Kyoto Economic Review 186(4):1-18 (2013) [in Japanese]

[3] Sengoku, S., A Consortium-Based Approach for Open Innovation: Exploring a Unique and Optimal Model for Japan And Stem Cell Technology, Hitotsubashi Business Review61(3):68-85 (2013) [in Japanese]


International Conferences (selected)

[1] Sengoku, S., Sumikura, K., Oki, T., The uptake and diffusion of innovations: a case of stem cell technology, the XXII International Societyfor Professional Innovation Management (ISPIM) Conference (Jun 2010). PDF

[2] Kusama R., Shime, T., Sengoku, S., Kawai, H., Kunieda, K., Yamada, K., Suematsu, C., Intellectual Productivity Management in Research Projects: Theoretical and Observational Approaches, Portland International Center for Management of Engineering and Technology (PICMET) Conference 2011 (Aug 2011)

[3] Sengoku, S., Sumikura, K., Oki, T., Redefining the Concept of Standardization for Pluripotent Stem Cells, Portland International Center for Management of Engineering and Technology (PICMET) Conference 2011 (Aug 2011)

[4] Anzai, T., Sengoku, S., A Management Framework for Interdisciplinary Research Projects: Empirical Study on the Collaboration Process and the Research Outcome, Portland International Center for Management of Engineering and Technology (PICMET) Conference 2011 (Aug 2011)

[5] Anzai, T., Sengoku, S., An Institutional Managerial Approach for Interdisciplinary Academic Research Projects, International Association for Management of Technology (IAMOT) Conference 2012 (Apr 2013)

[6] Munisi, H. I., Sengoku, S., Challenges in Commercializing Stem Cells and Regenerative Medicine Technologies: A Case Study on Dedicated Biotech Firms in Japan, Portland International Center for Management of Engineering and Technology (PICMET) Conference 2013 (Jul-Aug 2013)

[7] Xie, Z., Sengoku, S., Heterogeneities and patterns of innovations in life sciences sector: the case of stem cells employing patent families dataPortland International Center for Management of Engineering and Technology (PICMET) Conference 2013 (Jul-Aug 2013)

[8] Nishijima, Y., Sengoku, S., Anzai, T., Application of bibliometric analysis .to market analysisPortland International Center for Management of Engineering and Technology (PICMET) Conference 2013 (Jul-Aug 2013)

[9] Avila-Robinson, A., Sengoku, S., Changes and interactions in the technoscientificknowledge bases underpinning an emerging biotechnology field, Global TechMiningConference 2013 (Atranta, 24 Sep 2013)

[10] Sengoku, S., Munisi, H. I., Avila-Robinson, A., Exploring Innovative Research and Development through a Consortium-Based Approach. International Association for Management of Technology (IAMOT) 2014 (Washington D. C., May 22-26)

[11] Sakurai, S., Munisi, H.I., Kakihara, H., Sengoku, S., The Survey and Analysis on the Unlisted Biotech Drug Discovery/Development Firms (Biotech DDFs) in Japan: The Current Status and Created Values. Portland International Center for Management of Engineering and Technology (PICMET) Conference 2014 (Kanazawa, Jul 27-31 2014)

[12] Avila-Robinson, A., Shichijo, N., Sengoku, S., Evaluating the Evaluation of Interdisciplinary Research Projects: How to Manage the Discrepancy in Evaluation Methods. Portland International Center for Management of Engineering and Technology (PICMET) Conference 2014 (Kanazawa, Jul 27-31 2014)

[13] Avila-Robinson, A., Sengoku, S., Assessing the dynamics of knowledge-building of countries in the formation of emerging fields – A bibliometric approach on iPS cells. Portland International Center for Management of Engineering and Technology (PICMET) Conference 2014 (Kanazawa, Jul 27-31 2014)

[14] Jolivet, E., Ávila Robinson, A., Nohara, H., Sengoku, S. Accounting for the knowledge dynamics process of a science-based innovation, the XXVI International Society for Professional Innovation Management (ISPIM) Conference (Budapest, Jun 14-17 2015)

[15] Aoyama, T., Tanaka, S., Okamoto, Y., Nakamichi, M., Sato, K., Sengoku, S., Development of a Transport Tool for Regenerative Medicine, TERMIS 2015 World Congress (Boston, Sep 8-11 2015)

[16] Onodera, R., Sengoku, S., Miyazaki K., Exploring the Potential of Mobile Health for Product and Process Innovation,  Portland International Center for Management of Engineering and Technology (PICMET) Conference 2016 (Honolulu, 04-08 Sep 2016)

[17] Àvila-Robinson, A., Isram, N., Sengoku, S., What’s behind the curtain? ?Dissecting the dynamics of evolution of emerging stem cell-based therapies. Global TechMining Conference (Valéncia, 13 Sep 2016)


Reports (selected)

[1] Kondo, J.M., Sengoku, S., Nagata, A., Niino, Y., Shimada, H., Employment of Women and Health Policy [in Japanese], Policy Recommendations vol.2, Healthcare Policy Institute, Japan, Tokyo (2005) [in Japanese]

[2] Ministry of Health, Labour and Welfare, New vision for the pharmaceutical industry: Aiming at the industry with international competitive power taking the mission of innovation, appendix pp.34-36 (2007) [in Japanese]

[3] Oki, T., Sengoku, S., Sumikura, K., Bulletin of TEPIA Intellectual Property Academic Research Grant 2010, pp.10-22, ISSN:1883-4612 (2012) [in Japanese]

[4] The Hinxton Group, Statement on Data and Materials Sharing and Intellectual Property in Pluripotent Stem Cell Science in Japan and China (19 Nov 2012)


Commentaries (selected)

[1] Sengoku, S., Thinking about functional foods: Social innovation on dietary supplements [in Japanese], Food style 21 11(8):19-21 (2007) [in Japanese]

[2] Sengoku, S., Yoda, T., Seki, A., Fresh Look at Valuation of the Drug R&D [in Japanese], Diamond Harvard Business Review, April 2010 pp.137-139 (2010) [in Japanese]

[3] Hasegawa, K., Asada, T., Sengoku, S., Nakatsuji, N. World Stem Cell Summit 2014, Regenerative Medicine10(4), 393–396 (2015)


Invited Presentations (selected)

[1] 'Study on innovation management. for biomedical industrial clusters:. Case comparison of Edinburgh and Kyoto', MRC-CRM & iCeMS Joint Symposium "Next Generation Stem Cells: Tools and Technologies Symposium", Edinburgh, UK (25 Jul 2011)

[2] 'International Trends and Competencies of Stem Cells Research: Bibliometric Portfolio Analysis across Nations and Research Institutes', Special Seminar Hosted by Weissman Lab, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford, USA (16 Mar 2012)

[3] 'Taking a university department towards global excellence: How strategizing can make a difference: the case of iCeMS, Kyoto University', a seminar hosted by BioPeople at University of Copenhagen & Copenhagen Business School, Copenhagen, Denmark (2 Oct 2012)

[4] 'Scientometric Methods.for the Management of an Interdisciplinary Research Institute', the Workshop 'Building an Internationally Competitive Research Environment for University System of Taiwan', Hsinchu, Taiwan (4 Oct 2012)

[5] 'Innovation and Commercialization of Pluripotent Stem Cells', BIT's 5th Annual World Congress of Regenerative Medicine & Stem Cell-2012 (Guangzhou, China, 2-4 Dec 2012)

[6] 'Global competencies from regional stem cell research: A bibliometric approach for investigating and forecasting research trends', the 1st Bristol-Kyoto Symposium (Bristol, UK, 10-11 Jan 2013)

[7] 'Global competencies from regional stem cell research: A bibliometric approach for investigating and forecasting research trends', Stem Cells Australia Symposium (Melbourne, Australia, 12-13 Feb 2013)

[8] 'New Policy Design for Biocluster Development in Japan', International Workshop at the CEEJA: Regional Innovation Capability and Technology Transfer in Biotechnology Clusters, New Recipes in Japan and Europe? (Alsace, France, 19-20 Sep 2013)

[9] 'The Consortium-Based Approach and Entrepreneurship: .a Case of Stem Cell Research', Uppsala University-Tokyo Tech Joint Symposium (Tokyo, Nov 16-17 2015)

[10] 'Mobile Health Technologies: Promise, Prospects and Challenges', IEEE Hawaii Computer Society Chapter sponsored Disinguished Learning Seminar (Honolulu, 7 Sep 2016)

[11] 'Consortium-Based Open Innovatoin: Exploring a Unique and Optimal Model for Japan and Advanced Technology', 2016 Joint International Conference CNRS-EHESS/FFJ-JST/RISTEX (Tokyo, 13 Sep 2016)


© Copyright 2009- Dr Shintaro Sengoku. All rights reserved. 本内容の無断転載を禁じます。